Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Psychopharmacology (Berl). 2018 Sep 5;235(11):3167–3176. doi: 10.1007/s00213-018-5016-3

Table 1:

Participant characteristics (N = 62)

Variable Mean (SD) or % Range
Sex
   Men 43.5%
   Women 56.5%
Ethnicity/Race
   Non-Hispanic Black 51.6%
   Non-Hispanic White 48.4%
Current Tobacco Use
   Yes 16.1%
   No 83.9%
Average Number Weekly
Alcoholic Beverages Consumed
1.6 (2.8) 0 - 15
Age - years 41.9 (15.6) 19 - 77
PCS 8.7 (9.3) 0 - 57
Sleep Onset Latency 29.3 (52.8) 2 – 292.8
Wake After Sleep Onset 51.6 (25.7) 14.3 – 118.6
Total Sleep Time 388.3 (71.8) 209 - 614
Sleep Efficiency (%) 80.4 (10.2) 38.5 – 96.5
Average Daily Dietary Caffeine
Consumption (mg) – 7 days
170.8 (178.1) 0 – 643.6
Average Caffeine Consumption
Day of Pain Testing (mg)
115.1 (171.2) 0 – 608.8
HPTh 44.9 (3.1) 36 – 49.4
HPTo 48.5 (1.8) 42.3 – 51.5
PPT - Forearm 415.3 (177.6) 148.9 – 1000.1
PPT - Trapezius 464.6 (213.2) 147.6 – 1000.1

Note: SD = standard deviation; BMI = body mass index; PCS = Pain Catastrophizing Scale; PSQI = Pittsburgh Sleep Quality Index; mg = milligrams